Alisol A attenuates hypothalamic inflammation and metabolic dysfunction in high-fat diet mice

Area of Science:

• Neuroscience
• Metabolic research
• Pharmacology

Background:

• High-fat diet (HFD)-induced obesity is linked to hypothalamic inflammation and metabolic dysfunction.
• Alisol A (AA), a triterpenoid, possesses anti-inflammatory and metabolic regulatory properties.
• The effects of AA on HFD-induced hypothalamic dysfunction require systematic investigation.

Purpose of the Study:

• To investigate whether Alisol A (AA) treatment attenuates hypothalamic dysfunction during high-fat diet (HFD) exposure.
• To assess the impact of AA on systemic metabolism, hypothalamic inflammation, and neurobiological changes in HFD-fed mice.

Main Methods:

• Male mice were administered HFD with or without AA.
• Evaluated systemic metabolism, hypothalamic gliosis, cytokine levels, neurometabolites, functional connectivity, ultrastructure, behavior, and gene expression.
• Utilized magnetic resonance spectroscopy, functional MRI, transmission electron microscopy, and RNA sequencing.

Main Results:

• AA limited weight gain and improved glucose tolerance, insulin sensitivity, and lipid profiles in HFD-fed mice.
• AA partially corrected hypothalamic neurometabolic alterations, reduced gliosis and inflammation, and improved synaptic integrity.
• AA treatment enhanced learning and working memory performance and modulated hypothalamic inflammatory and metabolic gene expression.

Conclusions:

• Alisol A (AA) treatment ameliorates systemic metabolic disturbances in HFD-fed mice.
• AA improves hypothalamic function, reduces inflammation, and enhances cognitive performance.
• AA demonstrates potential as a therapeutic agent for HFD-induced obesity and associated neurobiological impairments.